CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Income Statement [Abstract]
Licensing revenue
Total revenues
Operating Expenses:
Research and development	$ 689,018	$ 770,099
Selling, general and administrative	$ 936,627	1,543,499
Loss on disposal of property and equipment		108,840
Depreciation and amortization	$ 30,656	86,704
Total operating expenses	1,656,301	2,509,142
Loss from operations	(1,656,301)	(2,509,142)
Other Income (Expense):
Loss on revaluation of derivative liabilities	$ (325,049)	(257,845)
Financing expense		(5,534,000)
Loss on early extinguishment of bridge loans	$ (415,725)	0
Amortization of debt discount	(184,966)	0
Interest expense	(39,187)	(2,725)
Other expense, net	(964,927)	(5,794,570)
Net loss	$ (2,621,228)	$ (8,303,712)
Net loss per common share, basic and diluted	$ (0.23)	$ (0.72)
Basic and diluted weighted average common shares outstanding	11,215,007	11,548,590